Interested in learning more about MedTechAI or becoming an investor? 

Contact John Cullen @ 416-433-6047 or john@jhiassociates.com

About MedTechAi

• MedTechAI is the financing arm of Oxford Immune Algorithmics (OIA)

• MedTechAI currently owns 28% of OIA. Financing to acquire another 10% equals ownership of 38% of OIA

• OIA, the creators of Algocyte, have scholarly roots at top global research institutions.

• Originated at Karolinska, incubated by the University Oxford, and co-developed with the University of Cambridge